4//SEC Filing
XEROX CORP 4
Accession 0001127602-13-024895
CIK 0000108772operating
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 3:24 PM ET
Size
19.6 KB
Accession
0001127602-13-024895
Insider Transaction Report
Form 4
XEROX CORPXRX
BLODGETT LYNN
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2013-08-08$6.33/sh+117,560$744,155→ 320,527 total - Sale
Common Stock
2013-08-08$9.92/sh−117,560$1,165,748→ 202,967 total - Exercise/Conversion
Common Stock
2013-08-09$7.10/sh+200,000$1,420,000→ 402,967 total - Exercise/Conversion
Stock Options
2013-08-09−200,000→ 152,358 totalExercise: $7.10From: 2010-02-05Exp: 2017-08-15→ Common Stock (200,000 underlying) - Exercise/Conversion
Common Stock
2013-08-08$7.10/sh+204,483$1,451,829→ 407,450 total - Exercise/Conversion
Stock Options
2013-08-08−117,560→ 850,235 totalExercise: $6.33From: 2010-02-05Exp: 2019-08-20→ Common Stock (117,560 underlying) - Exercise/Conversion
Stock Options
2013-08-08−204,483→ 352,358 totalExercise: $7.10From: 2010-02-05Exp: 2017-08-15→ Common Stock (204,483 underlying) - Sale
Common Stock
2013-08-08$10.01/sh−72,043$721,150→ 202,967 total - Sale
Common Stock
2013-08-08$9.92/sh−132,440$1,313,302→ 275,010 total - Sale
Common Stock
2013-08-09$9.99/sh−200,000$1,999,000→ 202,967 total
Footnotes (1)
- [F1]These options vest and become excercisable as follows: on each anniversary date of the grant, commencing with the first such anniversary date and continuing on each such anniversary thereafter through and including the fifth anniversary of the date of the grant, 20% of such options shall vest and become excercisable. The date of the grant is 10 years prior to the stated expiration date.
Documents
Issuer
XEROX CORP
CIK 0000108772
Entity typeoperating
IncorporatedCT
Related Parties
1- filerCIK 0000108772
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 3:24 PM ET
- Size
- 19.6 KB